Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-12-6
|
pubmed:abstractText |
We have investigated relations between hypotensive responses to LP-805, a newly synthesized vasodilator, and the production of nitric oxide (NO), in anesthetized rats. LP-805 (0.1-0.5 mg/kg, i.v.) or acetylcholine (ACh) (0.3-3.0 micrograms/kg, i.v.) caused a dose-dependent transient decrease in diastolic blood pressure. The decrease induced by 0.3 mg/kg LP-805 (i.v.) was partially inhibited by pretreatment with NG-nitro-L-arginine (L-NNA), a specific inhibitor of endothelial NO synthase, but the responses to lower or higher doses of LP-805 (0.1 or 0.5 mg/kg, i.v.) were not affected. The dose-dependent decrease in diastolic blood pressure, caused by LP-805, was not affected by pretreatment with L- or D-arginine. The dose-dependent decrease in diastolic blood pressure caused by ACh was not affected by pretreatment with L-NNA or with L- or D-arginine. The hypotensive response to 20-min infusions of LP-805 (100 micrograms/kg per min) was significantly inhibited by pretreatment with L-NNA (10 mg/kg, i.v.). The half-recovery times (T 1/2) of LP-805 or ACh-induced depressor responses were shortened by pretreatment with L-NNA. They were prolonged by L-arginine, but not by D-arginine. This shortening, by L-NNA, of the half-recovery time after LP-805 or ACh was reversed by L-arginine, but not by D-arginine. The T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin (1 mg/kg, i.v.). In the presence of L-NNA (10 mg/kg, i.v.), the T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/8-tert-butyl-6,7-dihydropyrrolo(3,2-...,
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0028-1298
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
178-83
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8232597-Acetylcholine,
pubmed-meshheading:8232597-Animals,
pubmed-meshheading:8232597-Arginine,
pubmed-meshheading:8232597-Blood Pressure,
pubmed-meshheading:8232597-Dose-Response Relationship, Drug,
pubmed-meshheading:8232597-Endothelium, Vascular,
pubmed-meshheading:8232597-Hypotension,
pubmed-meshheading:8232597-Indomethacin,
pubmed-meshheading:8232597-Injections, Intravenous,
pubmed-meshheading:8232597-Male,
pubmed-meshheading:8232597-Nitric Oxide,
pubmed-meshheading:8232597-Nitroarginine,
pubmed-meshheading:8232597-Pyrazoles,
pubmed-meshheading:8232597-Pyrimidines,
pubmed-meshheading:8232597-Rats,
pubmed-meshheading:8232597-Rats, Wistar,
pubmed-meshheading:8232597-Vasodilation,
pubmed-meshheading:8232597-Vasodilator Agents
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo.
|
pubmed:affiliation |
Pharmaceutical Research Laboratories, POLA R & D Laboratories, POLA Corporation, Yokohama, Japan.
|
pubmed:publicationType |
Journal Article
|